
Jan 9 (Reuters) - The U.S. Environmental Protection Agency will reassess the safety of herbicide paraquat, its administrator Lee Zeldin said on Friday on X, adding that the body is requiring manufacturers to thoroughly prove that current uses are safe in real-world conditions.
Syngenta, which markets paraquat under the brand name Gramoxone, is among the herbicide's major sellers.
The Swiss-based agricultural chemical company is facing several lawsuits in the U.S., where plaintiffs allege exposure to paraquat caused them to develop Parkinson's, a degenerative brain disease that leads to loss of muscle coordination.
It has previously said there was "no credible evidence" that paraquat causes Parkinson's.
In agricultural settings, paraquat is mostly applied to soybean, corn and cotton crop fields to control invasive weeds and grasses, according to the Environmental Protection Agency.
(Reporting by Costas Pitas and Pooja Menon; Editing by Alan Barona)
LATEST POSTS
- 1
Manhunt for Brown University shooter continues: FBI releases photos of suspect, announces $50K reward - 2
Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," Dec. 7, 2025 - 3
Turning into a Distributed Writer: My Composing Process - 4
5 Breakout Stars in Ongoing television Series - 5
Ancient eggshells shed new light on crocodiles that hunted prey from trees
Doctors thought he had cancer. An offhand suggestion led to a rare diagnosis.
As reefs vanish, assisted coral fertilization offers hope in the Dominican Republic
Chris Noth responds to backlash after seemingly shading 'Sex and the City' costar Sarah Jessica Parker: 'It is not news'
The Best Games Crossroads in History
From candy cane fishing to ornament switcharoo, here are some of the best games you can play with your loved ones this holiday season
Vote In favor of Your Number one Kind Of Food Conveyance Administration
The Most Paramount Crossroads in Olympic History
Sea Ice Hits New Low in Hottest Year on Record for the Arctic
Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list











